Product Images Abigale Lo
View Photos of Packaging, Labels & Appearance
- Estradiol Structural Formula - image 01
- Norethindrone Acetate Structural Formula - image 02
- Figure 1a: Mean Baseline-Uncorrected Estradiol and Estrone Serum Concentration-Time Profiles Following Multiple Doses of Estradiol and Norethindrone Acetate Tablets 1 mg/0.5 mg (N=24) - image 03
- Figure 1b: Mean Baseline-Uncorrected Norethindrone Serum Concentration-Time Profile Following Multiple Doses of Estradiol and Norethindrone Acetate Tablets 1 mg/0.5 mg (N=24) - image 04
- Figure 2: Mean Weekly Number of Moderate and Severe Hot Flushes in a 12-Week Study - image 05
- Figure 3: Mean Number of Moderate to Severe Hot Flushes for Weeks 0 Through 12 - image 06
- Figure 4: Patients Treated with Estradiol and Norethindrone Acetate Tablets 1 mg/0.5 mg with Cumulative Amenorrhea over Time Percentage of Women with no Bleeding or Spotting at any Cycle Through Cycle 13 Intent to Treat Population, LOCF - image 07
- Figure 5: Patients Treated with Estradiol and Norethindrone Acetate Tablets 0.5 mg/0.1 mg with Cumulative Amenorrhea over Time Percentage of Women with no Bleeding or Spotting at any Cycle Through Cycle 6, Intent to Treat Population, LOCF - image 08
- Figure 6: Percentage Change in Bone Mineral Density (BMD) ± SEM of the Lumbar Spine (L1-L4) for Estradiol and Norethindrone Acetate Tablets 1 mg/0.5 mg and Estradiol 0.5 mg (Intent to Treat Analysis with Last Observation Carried Forward) - image 09
- Patient Information Figure 1 - image 10
- Estradiol and Noretindrone Acetate Tablets 0.5 mg/0.1 mg Label - image 11
- Estradiol and Noretindrone Acetate Tablets 1 mg/0.5 mg Label - image 12
Product Label Images
The following 12 images provide visual information about the product associated with Abigale Lo NDC 70700-303 by Xiromed Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Estradiol Structural Formula - image 01
Norethindrone Acetate Structural Formula - image 02
Figure 1a: Mean Baseline-Uncorrected Estradiol and Estrone Serum Concentration-Time Profiles Following Multiple Doses of Estradiol and Norethindrone Acetate Tablets 1 mg/0.5 mg (N=24) - image 03
Figure 1b: Mean Baseline-Uncorrected Norethindrone Serum Concentration-Time Profile Following Multiple Doses of Estradiol and Norethindrone Acetate Tablets 1 mg/0.5 mg (N=24) - image 04
Figure 2: Mean Weekly Number of Moderate and Severe Hot Flushes in a 12-Week Study - image 05
This text provides information about the frequency of hot flushes per week in a study involving different treatments like placebo, 1 mg of Estradiol, and a combination of Estradiol and norethindrone acetate tablets (1mg/0.5 mg). The data is presented over a 12-week period.*
Figure 3: Mean Number of Moderate to Severe Hot Flushes for Weeks 0 Through 12 - image 06
Figure 4: Patients Treated with Estradiol and Norethindrone Acetate Tablets 1 mg/0.5 mg with Cumulative Amenorrhea over Time Percentage of Women with no Bleeding or Spotting at any Cycle Through Cycle 13 Intent to Treat Population, LOCF - image 07
Figure 5: Patients Treated with Estradiol and Norethindrone Acetate Tablets 0.5 mg/0.1 mg with Cumulative Amenorrhea over Time Percentage of Women with no Bleeding or Spotting at any Cycle Through Cycle 6, Intent to Treat Population, LOCF - image 08
Figure 6: Percentage Change in Bone Mineral Density (BMD) ± SEM of the Lumbar Spine (L1-L4) for Estradiol and Norethindrone Acetate Tablets 1 mg/0.5 mg and Estradiol 0.5 mg (Intent to Treat Analysis with Last Observation Carried Forward) - image 09
The text is not clear and appears to be garbled. Therefore, the description is not available.*
Patient Information Figure 1 - image 10
Estradiol and Noretindrone Acetate Tablets 0.5 mg/0.1 mg Label - image 11
This text provides information about a medication named "Abigale™ Lo" which consists of Estradiol and Norethindrone Acetate Tablets. The tablets are in blister packs containing 28 tablets each, with a total of 3 pouches. The medication has a strength of 0.5 mg/0.1 mg. The NDC (National Drug Code) for this medication is 70700-303-85.*
Estradiol and Noretindrone Acetate Tablets 1 mg/0.5 mg Label - image 12
This is a product description for Abigale™, which is a medication containing Estradiol and Norethindrone Acetate in tablet form. Each pouch contains one blister pack of 28 tablets with a dosage of 1 mg Estradiol and 0.5 mg Norethindrone Acetate. It is important to follow the prescribed dosage instructions when using this medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
